Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $257.78 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TRICE MEDICAL, INC. | $106.28 | 1 | $0 (2023) |
| Arthrex, Inc. | $95.92 | 1 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $32.45 | 2 | $0 (2017) |
| Abbott Laboratories | $23.13 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $129.41 | 2 | TRICE MEDICAL, INC. ($106.28) |
| 2018 | $95.92 | 1 | Arthrex, Inc. ($95.92) |
| 2017 | $32.45 | 2 | Ferring Pharmaceuticals Inc. ($32.45) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Diabetes Care | ||||||
| 08/21/2023 | TRICE MEDICAL, INC. | — | Food and Beverage | In-kind items and services | $106.28 | General |
| 12/26/2018 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $95.92 | General |
| 11/01/2017 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: ORTHOPEDICS | ||||||
| 10/19/2017 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: ORTHOPEDICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 612 | 3,864 | $1.1M | $152,318 |
| 2022 | 20 | 863 | 7,240 | $1.7M | $298,136 |
| 2021 | 19 | 783 | 5,189 | $1.1M | $226,410 |
| 2020 | 19 | 769 | 14,940 | $2.5M | $608,977 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 2023 | 22 | 2,740 | $715,359 | $80,817 | 11.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 216 | $69,856 | $22,132 | 31.7% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 61 | 104 | $34,673 | $9,961 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $30,264 | $9,494 | 31.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 32 | 67 | $77,573 | $7,923 | 10.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 38 | 127 | $86,233 | $7,168 | 8.3% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2023 | 16 | 56 | $24,987 | $5,538 | 22.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $11,423 | $3,706 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 18 | $8,023 | $2,671 | 33.3% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 19 | 20 | $15,167 | $1,070 | 7.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 14 | 31 | $7,472 | $761.89 | 10.2% |
| 76881 | Complete ultrasound scan of joint | Office | 2023 | 12 | 12 | $9,264 | $481.90 | 5.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 81 | 319 | $2,545 | $267.74 | 10.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 25 | 25 | $1,304 | $221.71 | 17.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 17 | $445.70 | $103.32 | 23.2% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 12 | 2,500 | $471,748 | $86,068 | 18.2% |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | Office | 2022 | 19 | 2,040 | $403,363 | $61,891 | 15.3% |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 2022 | 15 | 1,220 | $318,518 | $48,043 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 173 | 296 | $92,142 | $31,043 | 33.7% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 115 | 178 | $53,414 | $16,785 | 31.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 41 | 92 | $101,476 | $12,029 | 11.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 88 | 88 | $38,048 | $11,976 | 31.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 37 | 122 | $82,838 | $7,495 | 9.0% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2022 | 18 | 67 | $56,836 | $6,969 | 12.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 30 | $12,410 | $4,541 | 36.6% |
About Dr. Atul Gupta, MD
Dr. Atul Gupta, MD is a Sports Medicine healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1710236245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Atul Gupta, MD has received a total of $257.78 in payments from pharmaceutical and medical device companies, with $129.41 received in 2023. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($257.78).
As a Medicare-enrolled provider, Gupta has provided services to 3,027 Medicare beneficiaries, totaling 31,233 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Physical Medicine & Rehabilitation
- Location Seattle, WA
- Active Since 08/30/2012
- Last Updated 04/16/2018
- Taxonomy Code 2081S0010X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710236245
Products in Payments
- EUFLEXXA (Device) $32.45
- FREESTYLE LIBRE 3 (Device) $23.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Seattle
Dr. Grant Garcia, Md, MD
Sports Medicine — Payments: $220,780
Dr. Mia Hagen, M.d, M.D
Sports Medicine — Payments: $50,638
Dr. Adam Pourcho, D.o, D.O
Sports Medicine — Payments: $34,474
Dr. Winston Warme, Md, MD
Sports Medicine — Payments: $18,862
Thomas Byrnes, M.d, M.D
Sports Medicine — Payments: $11,689
Jake Checketts, Do, DO
Sports Medicine — Payments: $9,033